Docking Studies and Biological Activity of Fosinopril Analogs

الملخص EN

The purpose of the present study was to determine the angiotensin-I converting enzyme inhibitory activity of few novel Fosinopril derivatives which were predicted to possess better ACE inhibitory activity and lesser side effects than the existing drug molecule.

In vitro study was carried out to determine ACE inhibitory activity of six different Fosinopril analogs by spectrophotometric assay procedure.

Analog A2 showed the highest activity compared to other analogs and as well as Fosinopril itself.

Docking studies of the compounds were done with the help of VLife MDS 3.0 software using GRIP batch docking method to find out which derivative had a better docking with ACE.

The compounds which showed the highest negative score in docking have also exhibited good ACE inhibitory activity.